Mehić, Bakir, Mirko Stanetić, Ljuljeta Tinjić, and Vlatka Smoljanović. 2008. “Our Experiences With Erlotinib in Second and Third Line Treatment Patients With Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer”. Biomolecules and Biomedicine 8 (4):386-90. https://doi.org/10.17305/bjbms.2008.2905.